FDA Orange Book · active-ingredient family
Meclizine hydrochloride
Meclizine hydrochloride is approved as 1 brand and 37 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ANTIVERT · NDA 010721
1
Brand (NDA)
37
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, tablet, chewable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ANTIVERTRLD×4 | CASPER PHARMA LLC | NDA 010721 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (37)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MECLIZINE HYDROCHLORIDE×3 | CHARTWELL RX | ANDA 203003 | AA | Aug 11, 2022 | |
| MECLIZINE HYDROCHLORIDE | INVAGEN PHARMS | ANDA 200791 | — | Feb 17, 2022 | |
| MECLIZINE HYDROCHLORIDE×3 | INVAGEN PHARMS | ANDA 200432 | — | Feb 17, 2022 | |
| MECLIZINE HYDROCHLORIDE×2 | ZYDUS LIFESCIENCES | ANDA 213957 | AA | Jun 23, 2020 | |
| MECLIZINE HYDROCHLORIDE×3 | HERITAGE | ANDA 205136 | — | Feb 22, 2019 | |
| MECLIZINE HYDROCHLORIDE×3 | AUROBINDO PHARMA USA | ANDA 202640 | AA | Sep 17, 2012 | |
| MECLIZINE HYDROCHLORIDE×2 | EPIC PHARMA LLC | ANDA 200294 | AA | Apr 13, 2012 | |
| MECLIZINE HYDROCHLORIDE×3 | AMNEAL PHARMS | ANDA 201451 | AA | Feb 23, 2011 | |
| MECLIZINE HYDROCHLORIDE×2 | JUBILANT CADISTA | ANDA 040659 | AA | Jun 04, 2010 | |
| MECLIZINE HYDROCHLORIDE×2 | RISING | ANDA 040179 | — | Jan 30, 1997 | |
| MECLIZINE HYDROCHLORIDE | SANDOZ | ANDA 084843 | AA | May 22, 1989 | |
| MECLIZINE HYDROCHLORIDE | SCIEGEN PHARMS | ANDA 084092 | AA | May 22, 1989 | |
| MECLIZINE HYDROCHLORIDE | STRIDES PHARMA INTL | ANDA 089674 | — | Mar 31, 1988 | |
| MECLIZINE HYDROCHLORIDE | PLIVA | ANDA 088733 | — | Dec 11, 1985 | |
| MECLIZINE HYDROCHLORIDE | ANI PHARMS | ANDA 088732 | — | Dec 11, 1985 | |
| MECLIZINE HYDROCHLORIDE | PLIVA | ANDA 088734 | — | Dec 11, 1985 | |
| MECLIZINE HYDROCHLORIDE | SUPERPHARM | ANDA 089113 | — | Aug 20, 1985 | |
| MECLIZINE HYDROCHLORIDE | SUPERPHARM | ANDA 089114 | — | Aug 20, 1985 | |
| MECLIZINE HYDROCHLORIDE | UDL | ANDA 088256 | — | Jun 13, 1983 | |
| MECLIZINE HYDROCHLORIDE | UDL | ANDA 088257 | — | Jun 13, 1983 | |
| MECLIZINE HYDROCHLORIDE | VANGARD | ANDA 087877 | — | Apr 20, 1982 | |
| MECLIZINE HYDROCHLORIDE | VANGARD | ANDA 087620 | — | Jan 04, 1982 | |
| MECLIZINE HYDROCHLORIDE | IVAX SUB TEVA PHARMS | ANDA 084976 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | NEXGEN PHARMA INC | ANDA 086392 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | ABC HOLDING | ANDA 085253 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | ABC HOLDING | ANDA 085252 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | ANABOLIC | ANDA 085891 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE×2 | ANI PHARMS | ANDA 084657 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | ANI PHARMS | ANDA 085269 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | ANI PHARMS | ANDA 085740 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | BUNDY | ANDA 084382 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | BUNDY | ANDA 084872 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | IVAX SUB TEVA PHARMS | ANDA 083784 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | KV PHARM | ANDA 085524 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | KV PHARM | ANDA 085523 | — | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE×2 | SENORES PHARMS | ANDA 087128 | AA | Approved Prior to Jan 1, 1982 | |
| MECLIZINE HYDROCHLORIDE | WATSON LABS | ANDA 085195 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Meclizine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

